JAZZ Dividend: Jazz Pharmaceuticals PLC Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

JAZZ Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4,157	4,068	3,834	3,659	3,094	2,363
Revenue Growth (YoY)	4%	6%	5%	18%	31%	9%
Cost of Revenue	478	445	435	540	440	148
Gross Profit	3,679	3,623	3,398	3,118	2,653	2,214
Selling, General & Admin	1,772	1,385	1,262	1,376	1,222	854
Research & Development	809	884	849	1,034	505	586
Operating Expenses	3,225	2,896	2,720	3,010	2,254	1,700
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-703	470	297	-372	-112	275
Income Tax Expense	-335	-91	-119	-158	216	33
Net Income	-368	560	414	-224	-329	238
Net Income Growth	-179%	35%	-285%	-32%	-238%	-54%
Shares Outstanding (Diluted)	61.6	66	72.06	62.5	59.7	56.5
Shares Change (YoY)	-2%	-8%	15%	5%	6%	-2%
EPS (Diluted)	-5.98	8.48	5.75	-3.58	-5.52	4.22
EPS Growth	-182%	47%	-261%	-35%	-231%	-54%
Free Cash Flow	1,239	1,347	1,049	773	733	520
Free Cash Flow Per Share	20.11	20.4	14.55	12.36	12.27	9.2
Gross Margin	88.5%	89.06%	88.62%	85.21%	85.74%	93.69%
Operating Margin	10.89%	17.84%	17.68%	2.95%	12.89%	21.75%
Profit Margin	-8.85%	13.76%	10.79%	-6.12%	-10.63%	10.07%
Free Cash Flow Margin	29.8%	33.11%	27.36%	21.12%	23.69%	22%
EBITDA	1,096	1,353	1,286	707	924	773
EBITDA Margin	26.36%	33.25%	33.54%	19.32%	29.86%	32.71%
D&A For EBITDA	643	627	608	599	525	259
EBIT	453	726	678	108	399	514
EBIT Margin	10.89%	17.84%	17.68%	2.95%	12.89%	21.75%
Effective Tax Rate	47.65%	-19.36%	-40.06%	42.47%	-192.85%	12%